Stockscreener 앱 받기
40.61
4.29%
-1.82
시간 외 거래:
40.62
0.010
+0.02%
전일 마감가:
$42.43
열려 있는:
$42.51
하루 거래량:
657.57K
Relative Volume:
0.85
시가총액:
$2.36B
수익:
$32.87M
순이익/손실:
$674.31M
주가수익비율:
3.5748
EPS:
11.36
순현금흐름:
$-330.11M
1주 성능:
+0.27%
1개월 성능:
+13.82%
6개월 성능:
+60.45%
1년 성능:
-2.89%
1일 변동 폭
$40.20
$42.51
1주일 범위
$40.20
$43.21
52주 변동 폭
$23.41
$62.58
Agios Pharmaceuticals Inc Stock (AGIO) Company Profile
명칭
Agios Pharmaceuticals Inc
전화
617-649-8600
주소
88 SIDNEY STREET, CAMBRIDGE, MA
AGIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AGIO
Agios Pharmaceuticals Inc
|
40.61 | 2.47B | 32.87M | 674.31M | -330.11M | 11.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-24 | 개시 | H.C. Wainwright | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-09-27 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-02-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-03 | 개시 | Piper Sandler | Overweight |
| 2022-11-17 | 업그레이드 | Goldman | Sell → Neutral |
| 2022-07-27 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-03 | 개시 | BofA Securities | Buy |
| 2021-07-30 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-07-01 | 개시 | Raymond James | Mkt Perform |
| 2021-06-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-03-01 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-02-26 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-10-22 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-03-04 | 개시 | Barclays | Equal Weight |
| 2019-11-26 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-09-23 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-05-23 | 재개 | Goldman | Neutral |
| 2019-02-15 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2018-09-25 | 개시 | Leerink Partners | Mkt Perform |
| 2018-05-23 | 개시 | Citigroup | Buy |
| 2018-04-11 | 재확인 | Credit Suisse | Outperform |
| 2018-02-15 | 재확인 | Needham | Buy |
| 2018-02-15 | 재확인 | SunTrust | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
| 2017-08-10 | 재확인 | Needham | Buy |
| 2017-08-08 | 재확인 | SunTrust | Buy |
| 2017-08-02 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2017-06-26 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-01-17 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2016-10-24 | 개시 | Needham | Buy |
| 2016-06-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2016-05-18 | 재확인 | SunTrust | Buy |
모두보기
Agios Pharmaceuticals Inc 주식(AGIO)의 최신 뉴스
Why Agios Pharmaceuticals Inc. (8AP) stock gets analyst attentionJuly 2025 Retail & Risk Managed Investment Signals - newser.com
Will Agios Pharmaceuticals Inc. continue its uptrendMarket Sentiment Review & Precise Buy Zone Identification - newser.com
Has Agios Pharmaceuticals Inc. formed a bullish divergenceEarnings Miss & Daily Technical Stock Forecast Reports - newser.com
Zacks Research Issues Pessimistic Outlook for AGIO Earnings - MarketBeat
Will Agios Pharmaceuticals Inc. outperform the marketForecast Cut & AI Forecast for Swing Trade Picks - newser.com
Will Agios Pharmaceuticals Inc. (8AP) stock outperform Dow JonesPortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
What to expect from Agios Pharmaceuticals Inc. in the next 30 daysEarnings Recap Summary & Smart Money Movement Alerts - newser.com
Analyzing recovery setups for Agios Pharmaceuticals Inc. investorsJuly 2025 Catalysts & Smart Allocation Stock Reports - newser.com
How to use a screener to detect Agios Pharmaceuticals Inc. breakoutsWeekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
Using R and stats models for Agios Pharmaceuticals Inc. forecasting2025 Trading Volume Trends & Weekly High Return Stock Opportunities - newser.com
Relative strength of Agios Pharmaceuticals Inc. in sector analysisTrade Volume Report & Scalable Portfolio Growth Methods - newser.com
Leading vs lagging indicators on Agios Pharmaceuticals Inc. performanceWeekly Trade Review & Safe Entry Trade Signal Reports - newser.com
Agios Pharmaceuticals' (AGIO) Hold (C-) Rating Reiterated at Weiss Ratings - MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) Cut to "Strong Sell" at Zacks Research - MarketBeat
Agios Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
How Agios Pharmaceuticals Inc. stock reacts to bond yieldsJobs Report & Free Fast Entry Momentum Trade Alerts - newser.com
Will Agios Pharmaceuticals Inc. see short term momentumPortfolio Growth Summary & Weekly Breakout Watchlists - newser.com
Will Agios Pharmaceuticals Inc. stock benefit from commodity prices2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc.AGIO - Eastern Progress
What momentum shifts mean for Agios Pharmaceuticals Inc.July 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Is Agios Pharmaceuticals Inc. reversing from oversold territoryQuarterly Trade Summary & Free Verified High Yield Trade Plans - newser.com
Published on: 2025-10-02 19:48:50 - newser.com
Agios Pharmaceuticals Hits Day High with 9.64% Surge in Stock Price - Markets Mojo
Published on: 2025-10-01 06:17:51 - newser.com
Agios Pharmaceuticals Inc Stock Analysis and ForecastDividend Yield Trends & Rapid Portfolio Trading Growth - earlytimes.in
Beta Thalassemia Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | Agios Pharma, Vertex Pharma, Pharmacosmos, Editas Medicine, HemaQuest Pharma Q, Acceleron Pharma - Barchart.com
Agios Pharmaceuticals Inc (AGIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Agios Pharmaceuticals Inc 주식 (AGIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Scadden David | Director |
Oct 08 '25 |
Sale |
41.00 |
200 |
8,200 |
17,603 |
5.74%
자본화:
|
볼륨(24시간):